Tag - ANCA-Associated Vasculitis

  • Home
  • Tag -
  • ANCA-Associated Vasculitis

Latest ISN Journal Editorial Selections

Kidney International® Executive Summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis Since the 2021 Kidney Disease: Improving Global Outcomes (KDIGO) Guideline for the Management of Glomerular Diseases was published, important data concerning anti-neutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) has become available. These include the regulatory approval of avacopan for ANCA-AAV...

March 18, 2024Journals, NewsRead more...

South Asia Regional Board Webinar: ANCA-Associated Vasculitis: current understanding and treatment

Antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitides are a heterogeneous group of rare autoimmune conditions that cause inflammation of blood vessels with various manifestations mainly involving the kidney and lung. The incidence is 10-20 cases per million population, mainly affecting people in the 5th decade of life. ANCA-associated Vasculitis includes three main diseases: granulomatosis with polyangiitis, microscopic...

August 19, 2022News, Regional ActivitiesRead more...